...
首页> 外文期刊>Chemical research in toxicology >In Vitro Biotransformation of 3,4-Dihydro-6-hydroxy- 2,2-dimethyl-7-methoxy-l(2H)-Benzopyran (CR-6),a Potent Lipid Peroxidation Inhibitor and Nitric Oxide Scavenger,in Rat Liver Microsomes
【24h】

In Vitro Biotransformation of 3,4-Dihydro-6-hydroxy- 2,2-dimethyl-7-methoxy-l(2H)-Benzopyran (CR-6),a Potent Lipid Peroxidation Inhibitor and Nitric Oxide Scavenger,in Rat Liver Microsomes

机译:3,4-二氢-6-羟基-2,2-二甲基-7-甲氧基-1(2H)-苯并吡喃(CR-6),脂质过氧化抑制剂和一氧化氮清除剂在大鼠肝微粒体内的体外生物转化

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The in vitro metabolism of 3,4-dihydro-6-hydroxy-2,2-dimethyl-7-methoxy-l(2H)-benzopyran (CR-6),a potent lipid peroxidation inhibitor and scavenger of nitric oxide and peroxynitrite species that is currently in phase II trials for antitumoral therapy,has been investigated in rat liver microsomes in the presence of NADP(H).Five major metabolites were identified by comparison with authentic standards,namely,the quinone 2-(3'-hydroxy-3'-methylbutyl-5-methoxy-l,4-benzoquinone (2a) and its ring-closed spiro form oxaspiro[4.5]-2,2-dimethyl-8-methoxy-dec-8-ene-7,10-dione (2b),the hydroquinone 2-(3'-hydroxy-3'-methylbutyl)-5-meth-oxyhydroquinone (3),the hydroxylated metabolite 3,4-dihydro-4,6-dihydroxy-2,2-dimethyl-7-methoxy-l(2H)-benzopyran (4),and the catechol 3,4-dihydro-6,7-dihydroxy-2,2-dimethyl-l(2H)-benzopyran (5).When the incubations were carried out in the presence of GSH,the HPLC peaks corresponding to the quinone metabolites 2a/b were absent and two novel products were formed showing MS fragmentation patterns consistent with the structure of GSH conjugates of quinone 2a.The time dependence on the formation of metabolites 2a,b and 3 was measured in incubations induced with phenobarbital (PB),dexamethasone,and beta-naphthoflavone (betaNF).For the dexamethasone-induced microsomes,the amount of hydroquinone 3 decreased from minute 10 to minute 30 while that of 2a,b increased in a complementary manner.Similar effects were observed for the incubations carried out using PB- and betaNF-induced microsomes.On the other hand,CR-6 inhibited 7-ethoxyresorufin O-dealkylation activity (IC_(50)=25 muM) in incubations with /?NF-induced microsomes.Likewise,addition of pentoxyresorufin to the incubations of CR-6 with PB-induced microsomes showed a time-dependent inhibition (IC_(50)=75 muM) of the dealkylation activity.These results are in agreement with the putative generation of reactive metabolites from CR-6 that could deactivate P450 1A and P450 2B,respectively.When these incubations were carried out in the presence of 10 mM GSH,the inhibition of P450 2B could be partially prevented.Finally,preincubation of CR-6 with liver microsomes from PB-induced rats resulted in a strong increase in microsomal glutathione S-transferase (mGST) activity (up to a maximum of approximately 5-fold).When the preincubation was carried out in the presence of 10 mM GSH,the activation of mGST was blocked.Overall,these results suggest that CR-6 undergoes in vitro biotransformation indicative of the involvement of thiol-reactive metabolites.
机译:3,4-二氢-6-羟基-2,2-二甲基-7-甲氧基-1(2H)-苯并吡喃(CR-6)(一种有效的脂质过氧化抑制剂和一氧化氮和过氧亚硝酸盐清除剂)的体外代谢目前已经在抗肿瘤治疗的II期临床试验中,在存在NADP(H)的大鼠肝微粒体中进行了研究。通过与真实标准品进行比较,鉴定出5种主要代谢物,即醌2-(3'-羟基- 3'-甲基丁基-5-甲氧基-1,4-苯醌(2a)及其闭环螺环形式氧杂螺[4.5] -2,2-二甲基-8-甲氧基-dec-8-ene-7,10-二酮(2b),对苯二酚2-(3'-羟基-3'-甲基丁基)-5-甲基-氧氢醌(3),羟基化代谢产物3,4-二氢-4,6-二羟基-2,2-二甲基- 7-甲氧基-1(2H)-苯并吡喃(4)和邻苯二酚3,4-二氢-6,7-二羟基-2,2-二甲基-1(2H)-苯并吡喃(5)。 GSH存在下,没有对应于醌代谢物2a / b的HPLC峰,形成了两种新产物g的质谱碎片化模式与醌2a的GSH共轭物的结构一致。在苯巴比妥(PB),地塞米松和β-萘黄酮(betaNF)诱导的孵育中,测定了与代谢物2a,b和3形成时间相关的时间。在地塞米松诱导的微粒体中,对苯二酚3的量从第10分钟减少到第30分钟,而2a,b的量以互补的方式增加。使用PB和betaNF诱导的微粒体进行的孵育观察到相似的效果。另一方面,在与/?NF诱导的微粒体孵育中,CR-6抑制了7-乙氧基间苯二酚的O-去烷基化活性(IC_(50)= 25μM)。结果表明,脱烷基活性受到时间的抑制(IC_(50)= 75μM)。这些结果与推定的CR-6反应性代谢产物的产生相一致,可以分别使P450 1A和P450 2B失活。在含10 mM GSH的条件下进行了部分检测,可以部分阻止P450 2B的抑制作用。最后,将PB诱导的大鼠肝微粒体与CR-6预孵育会导致微粒体谷胱甘肽S-转移酶(mGST)的强烈增加活性(最多约5倍)。当在10 mM GSH存在下进行预孵育时,mGST的激活被阻断。总体而言,这些结果表明CR-6经历了体外生物转化,表明硫醇反应性代谢产物的参与。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号